Review of Candidate Genes for Cannabis Use Disorders Found Promising Leads and Major Challenges
Linkage studies identified chromosomal regions on seven chromosomes harboring cannabis disorder risk genes, while candidate gene studies focused on CNR1, CB2, FAAH, and dopamine/GABA/opioid system genes.
Quick Facts
What This Study Found
This review synthesized the genetic research on cannabis use disorders, covering both linkage studies (mapping chromosomal regions) and candidate gene association studies.
Four linkage studies identified regions on chromosomes 1, 3, 4, 9, 14, 17, and 18. Notable candidates within these regions included MGLL (monoglyceride lipase, on chromosome 3) and a novel gene ELTD1 on chromosome 1.
Candidate gene studies examined two categories: cannabis-specific genes (CNR1/CB1 receptor, CB2, FAAH, MGLL, TRPV1, GPR55) and general addiction genes from dopamine (DRD2), GABA (GABRA2), and opioid (OPRM1) systems.
The review highlighted four major challenges: understanding biological complexity including gene-gene and gene-environment interactions; choosing between diagnostic and quantitative phenotypes; distinguishing which stage of cannabis involvement (use, misuse, dependence) genes influence; and problems of sample composition.
Key Numbers
Regions on chromosomes 1, 3, 4, 9, 14, 17, and 18 identified. Cannabis-specific candidate genes: CNR1, CB2, FAAH, MGLL, TRPV1, GPR55. Non-specific candidates: GABRA2, DRD2, OPRM1.
How They Did This
Review of peer-reviewed linkage and candidate gene association studies related to cannabis use disorders, organized by study type and gene system.
Why This Research Matters
Understanding the genetic basis of cannabis use disorders could lead to better prediction of who is at risk and potentially targeted prevention strategies. The review mapped the landscape of genetic knowledge and identified critical research gaps.
The Bigger Picture
This review was published just before genome-wide association studies (GWAS) began providing much larger-scale genetic data on substance use disorders. Many of the candidate genes reviewed here have since been examined in GWAS, with some findings replicated and others not.
What This Study Doesn't Tell Us
Most candidate gene studies had small samples prone to false positives. Linkage studies identify broad regions, not specific genes. The review predated GWAS era. Gene-environment interaction studies were largely absent.
Questions This Raises
- ?Do cannabis-specific genes (like CNR1, FAAH) confer risk specifically for cannabis disorders or for addiction generally?
- ?How do genetic and environmental risk factors interact?
Trust & Context
- Key Stat:
- Chromosomes 1, 3, 4, 9, 14, 17, and 18 harbor potential cannabis disorder risk genes
- Evidence Grade:
- This is a comprehensive review of the pre-GWAS genetic literature, providing moderate evidence for genetic contributions to cannabis use disorders with acknowledged limitations.
- Study Age:
- Published in 2009. GWAS studies since then have identified specific genetic variants associated with cannabis use, confirming some candidate genes and identifying new ones.
- Original Title:
- Candidate genes for cannabis use disorders: findings, challenges and directions.
- Published In:
- Addiction (Abingdon, England), 104(4), 518-32 (2009)
- Authors:
- Agrawal, Arpana(39), Lynskey, Michael T(26)
- Database ID:
- RTHC-00339
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Is there a "cannabis addiction gene"?
No single gene determines cannabis addiction risk. Multiple genes, each contributing a small effect, combine with environmental factors. This review identified several candidate genes in both the cannabinoid system and general reward pathways.
Can genetic testing predict cannabis addiction risk?
Not yet with clinical utility. While genetic contributions to cannabis use disorders are established (about 50-70% heritable in twin studies), the specific genetic variants identified explain only a small fraction of that risk. Genetic testing for addiction risk is not currently recommended.
Read More on RethinkTHC
- cannabis-cardiovascular-heart-risk-stroke
- cannabis-heart-cardiovascular-risk
- coughing-up-stuff-after-quitting-weed
- lung-recovery-after-quitting-smoking-weed
- lung-recovery-quitting-weed
- quitting-weed-female-hormones
- quitting-weed-weight-gain-loss-diet-appetite
- sex-after-quitting-weed
- weed-DUI-driving-impaired-cannabis-laws
- weed-acne-skin
- weed-fertility-sperm
- weed-gut-digestion-problems
- weed-heart-health
- weed-testosterone-levels
Cite This Study
https://rethinkthc.com/research/RTHC-00339APA
Agrawal, Arpana; Lynskey, Michael T. (2009). Candidate genes for cannabis use disorders: findings, challenges and directions.. Addiction (Abingdon, England), 104(4), 518-32. https://doi.org/10.1111/j.1360-0443.2009.02504.x
MLA
Agrawal, Arpana, et al. "Candidate genes for cannabis use disorders: findings, challenges and directions.." Addiction (Abingdon, 2009. https://doi.org/10.1111/j.1360-0443.2009.02504.x
RethinkTHC
RethinkTHC Research Database. "Candidate genes for cannabis use disorders: findings, challe..." RTHC-00339. Retrieved from https://rethinkthc.com/research/agrawal-2009-candidate-genes-for-cannabis
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.